Stay updated on Anitocabtagene-autoleucel in MM Clinical Trial
Sign up to get notified when there's something new on the Anitocabtagene-autoleucel in MM Clinical Trial page.

Latest updates to the Anitocabtagene-autoleucel in MM Clinical Trial page
- Check7 days agoChange DetectedEligibility and Study Status were updated in the study history. A new version (14) was added on 2026-02-09, with subsequent updates on 2026-02-11, and a change from 2025-12-18 was removed.SummaryDifference0.5%

- Check14 days agoChange DetectedA new revision entry v3.4.2 was added to the history, and the prior government funding/operating status notice was removed; these are routine page maintenance updates.SummaryDifference0.7%

- Check21 days agoChange DetectedAdded a government funding notice and a new site revision tag Revision: v3.4.1. The previous revision Revision: v3.4.0 was removed.SummaryDifference0.7%

- Check28 days agoChange DetectedGlossary toggle is now visible, and changes are color-coded (green for additions, red for deletions) with the revision label showing Revision: v3.4.0.SummaryDifference0.9%

- Check42 days agoChange DetectedA new revision entry v3.3.4 was added and the previous revision v3.3.3 was removed in the page history, reflecting a minor history update.SummaryDifference0.1%

- Check64 days agoChange DetectedThe study history shows the addition of Study Design and Study Status entries on 2025-12-18 and 2025-12-17 (Revision: v3.3.3), and the deletion of the HHS Vulnerability Disclosure entry on 2025-11-13 (Revision: v3.3.2).SummaryDifference0.7%

Stay in the know with updates to Anitocabtagene-autoleucel in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anitocabtagene-autoleucel in MM Clinical Trial page.